Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Vulcan Value Partners - Large Cap. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+9.5%
YTD-5.9%
Annualized+9.3%
Positioning StanceNEUTRAL
Market CapLarge Cap
GeographyUS
Digest Analysis
Quick Take
"Vulcan owns exceptional businesses at 50 cents on the dollar with values compounding steadily despite near-term underperformance. Healthcare insurers UnitedHealth and Elevance are recovering from post-Covid pressure."
Executive Summary
Vulcan Value Partners delivered 9.5% net returns in Q2 2026 but remains down 5.9% year-to-date as the portfolio's deeply discounted, out-of-favor businesses lagged the broader market. Despite solid absolute returns, price-to-value ratios remained unchanged as portfolio companies reported strong results and generated robust free cash flow while the manager reallocated capital from names approaching fair value into more discounted opportunities. The portfolio added Equifax, a dominant credit bureau and workforce data provider trading at a discount despite strong fundamentals and no meaningful AI threat. Healthcare holdings UnitedHealth and Elevance were material contributors as the market began recognizing their recovery from post-Covid margin pressure. The manager emphasizes owning exceptional businesses at roughly 50 cents on the dollar with values compounding steadily. With companies significantly more undervalued than what is working in the market, the manager views this as a fantastic opportunity for long-term investors and personally added capital in Q1. The combination of steady value growth and substantial margins of safety historically leads to outsized returns over time.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
78%
CautiousHigh
High Conviction (78%)
The manager demonstrates high conviction through concentrated positioning (core positions at 5%), named holdings with detailed thesis explanations, and personal capital addition in Q1. Specific position sizing language is used (UnitedHealth increased 35% before exit, Equifax's Workforce Solutions is 60% of EBIT). The manager is willing to reallocate capital decisively and holds through volatility. However, the portfolio maintains 20+ positions across strategies with some diversification, and hedging language appears occasionally (we believe, should be able to). The explanation of specific holdings, sizing decisions, and personal co-investment supports a high conviction score, but the diversified nature of the strategy and some uncertainty acknowledgment prevents a score above 0.80.
Growth Outlook
15%
BearishBullish
Bearish (15%)
The manager acknowledges the market is arguably overvalued and not cheap by almost any metric. Companies in the portfolio remain deeply out of favor while what is working in the market is less undervalued. This reflects a cautious view of overall market conditions, though not strongly bearish. The manager notes paying a short-term price for positioning but does not express alarm about systemic risks.
Risk Appetite
60%
DefensiveAggressive
Balanced (60%)
The portfolio is fully invested in concentrated positions with most businesses repurchasing shares. The manager is actively reallocating capital from less discounted names into more discounted opportunities and personally added capital in Q1. This demonstrates a clear risk-on posture and willingness to deploy capital, though not at maximum aggression given the selective reallocation approach rather than broad deployment.
Capital Deployment
35%
De-riskingDeploying
Net Neutral (35%)
The manager is selectively deploying capital through reallocation rather than net new deployment. Capital was moved from Sodexo, Partners Group, and UnitedHealth (after appreciation) into more discounted names like Equifax. The manager added to existing positions when volatility created attractive entry points. The manager personally added capital in Q1. However, there is no evidence of cash levels declining or broad-based deployment. This represents active rotation and selective opportunistic buying rather than aggressive net deployment, warranting a moderate positive score.
Forward Guidance
55%
CautiousExpansionary
Neutral (55%)
The manager explicitly states it is an excellent time to add capital and encourages investors to follow their lead after personally adding capital in Q1. The letter emphasizes selectively adding to positions when price-to-value ratios become more attractive. However, the deployment is selective and opportunistic rather than aggressive across-the-board buying, indicating a moderately positive action bias.
Language Signal
50%
BearishBullish
Balanced (50%)
The letter balances opportunity language (fantastic opportunity, excellent time to add capital, exceptional businesses, substantial margin of safety, attractive, compelling) with acknowledgment of challenges (deeply out of favor, paid a short-term price, underperformance). The tone is constructive about portfolio positioning and long-term prospects while acknowledging near-term headwinds. The language is more opportunity-focused than risk-focused but not overwhelmingly bullish.
Perceived Risk
45%
Low RiskElevated
Moderate Risk (45%)
The manager acknowledges the market is arguably overvalued and not cheap, and notes paying a short-term price for positioning. AI disruption risks are mentioned as being monitored across portfolio companies. However, risk discussion is limited and not central to the letter. The manager expresses confidence in portfolio positioning and views current conditions as an opportunity rather than a threat. Specific risks to individual holdings (mortgage weakness for Equifax, post-Covid hangover for healthcare) are discussed but framed as temporary and manageable. The moderate risk acknowledgment without alarm or detailed downside scenarios supports a mid-range score.
Opportunity Density
70%
ScarceAbundant
Abundant (70%)
The manager describes a fantastic opportunity for serious long-term investors and states it is an excellent time to add capital. Multiple new positions were added (Equifax in Large Cap, plus others in other strategies) and the manager found compelling opportunities to reallocate capital into more discounted names. The letter emphasizes owning exceptional businesses at 50 cents on the dollar. However, the manager also notes that companies remain deeply out of favor and it is rare to find enough sufficiently discounted companies to warrant full concentration. This suggests selective rather than abundant opportunities, supporting a moderately high but not extreme score.
Time Horizon
75%
Short-TermLong-Term
Decade+ (75%)
The manager explicitly states placing no weight on short-term results and emphasizes a five-year investment horizon multiple times. The letter discusses long-term value creation, steady value compounding, and historical patterns over longer periods. The manager is willing to pay a short-term price for better long-term positioning. However, the letter also discusses quarterly results, near-term catalysts (earnings returning to double-digit growth next year for Elevance), and one-year performance windows. The fund structure allows quarterly redemptions, which constrains the time horizon compared to permanent capital vehicles. The multi-year thesis with explicit five-year horizon language supports a score in the 0.70-0.80 range.